Medicine Details
Brand name – Hepcvel
Generic name – Sofosbuvir-Velpatasvir
Manufacturer – Cipla Ltd
Salt composition – Sofosbuvir (400mg) + Velpatasvir (100mg)
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 400mg + 100 mg
Packaging – Bottle of 28 tablets
Gender – Unisex
Prescription required – Yes
Indication – Used in the treatment of Hepatitis C Virus infection
Description
Hepcvel (Sofosbuvir-Velpatasvir) tablet is used in the treatment of chronic Hepatitis C Virus (HCV) infection in adults. It works by lowering the multiplication of HCV in the body, and thereby removing the virus from the body. The active ingredient of Hepcvel, Sofosbuvir-Velpatasvir is the combination of two direct acting agents against the virus (HCV).
Pharmacodynamics
Hepcvel Tablets are an oral fixed-dose combination (FDC) of sofosbuvir and velpatasvir which are direct-acting antiviral agents against the hepatitis C virus (HCV). Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor. The effect of Sofosbuvir 400 mg (recommended dosage) and 1200 mg (three times the recommended dosage) on QTc interval was evaluated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. At a dose (three times the recommended dose), Sofosbuvir does not prolong QTc to any clinically relevant extent.The effect of Velpatasvir 500 mg (five times the recommended dosage) was evaluated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. At a dose (five times the recommended dose), Velpatasvir does not prolong QTc interval to any clinically relevant extent.
Ingredients
The active ingredient of Hepcvel is Sofosbuvir-Velpatasvir.
Usage Of Medicine
Hepcvel tablet is used in the treatment of chronic Hepatitis C Virus (HCV) infection in adults.
Alternate Brands
- Velpanat tablet
- Velasof tablet
- Veplaclear tablet
- Sofocure-v tablet


